BNP Paribas Financial Markets increased its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 57.3% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 57,555 shares of the health services provider's stock after buying an additional 20,972 shares during the quarter. BNP Paribas Financial Markets owned about 0.10% of Maximus worth $5,362,000 as of its most recent filing with the SEC.
A number of other large investors have also modified their holdings of MMS. V Square Quantitative Management LLC acquired a new stake in shares of Maximus in the third quarter valued at about $25,000. GAMMA Investing LLC grew its stake in Maximus by 224.5% during the 2nd quarter. GAMMA Investing LLC now owns 344 shares of the health services provider's stock valued at $29,000 after purchasing an additional 238 shares in the last quarter. Blue Trust Inc. grew its stake in Maximus by 201.5% during the 2nd quarter. Blue Trust Inc. now owns 392 shares of the health services provider's stock valued at $33,000 after purchasing an additional 262 shares in the last quarter. Archer Investment Corp grew its stake in Maximus by 8,788.9% during the 2nd quarter. Archer Investment Corp now owns 800 shares of the health services provider's stock valued at $69,000 after purchasing an additional 791 shares in the last quarter. Finally, Ariadne Wealth Management LP acquired a new stake in Maximus during the 2nd quarter valued at approximately $90,000. Institutional investors and hedge funds own 97.21% of the company's stock.
Maximus Stock Up 0.3 %
NYSE MMS traded up $0.25 during mid-day trading on Wednesday, reaching $74.83. 315,802 shares of the company's stock traded hands, compared to its average volume of 417,488. The company has a market cap of $4.51 billion, a price-to-earnings ratio of 14.92 and a beta of 0.73. The company has a fifty day simple moving average of $85.83 and a 200-day simple moving average of $87.40. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.59. Maximus, Inc. has a 1-year low of $71.75 and a 1-year high of $93.97.
Maximus Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Saturday, November 30th. Stockholders of record on Friday, November 15th were given a $0.30 dividend. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.60%. Maximus's payout ratio is 24.00%.
Analyst Upgrades and Downgrades
Separately, StockNews.com lowered Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, November 28th.
View Our Latest Stock Analysis on Maximus
Insider Transactions at Maximus
In related news, insider Michelle F. Link sold 1,363 shares of the firm's stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $92.56, for a total value of $126,159.28. Following the sale, the insider now owns 6,567 shares of the company's stock, valued at approximately $607,841.52. This trade represents a 17.19 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 1.40% of the company's stock.
Maximus Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Stories
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.